(Q36430744)

14 August 2017

1 reference

title

Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model (English)

1 reference

14 August 2017

1 reference

Tomonori Habuchi

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

2

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

233-245

1 reference

Lessons from hereditary colorectal cancer

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Genetic polymorphisms and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

International trends and patterns of prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The Prostate Cancer Prevention Trial: Current status and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Studies on Prostatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

A review of genetic polymorphisms and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Hormones and prostate cancer: what's next?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

5α-Reductase Type 1 Immunostaining is Enhanced in Some Prostate Cancers Compared With Benign Prostatic Hyperplasia Epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Molecular epidemiology of hormone-metabolic loci in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Transcriptional activation and transient expression of the human androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

A polymorphism in the CYP17 gene is associated with prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Local aromatase expression in human prostate is altered in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

From estrogen to androgen receptor: a new pathway for sex hormones in prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Roles of estrogen and SHBG in prostate physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a huge review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclins and cdks in development and cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclin D1 polymorphism and the risk of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

CCND1 polymorphism and age of onset of hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Role of nitric oxide in the modulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Role of insulin-like growth factor 1 receptor signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Hormonal predictors of prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The insulin-like growth factor-I receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cancer pharmacogenomics: current and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cancer drugs, genetic variation and the glutathione-S-transferase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Cytochrome P450 gene polymorphism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Genetic biomarkers of therapeutic radiation sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Association of HPC2/ELAC2 genotypes and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Association of HER-2 polymorphism with Japanese sporadic prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.2.233

21 January 2018

Identifiers

DOI

10.2217/14796694.2.2.233

1 reference

14 August 2017

1 reference